Blake Marggraff graduated from Washington University in May, 2015 and founded the digital health company Epharmix, based on research around chronic disease management for medically underserved patient populations. Epharmix has demonstrated meaning clinical outcomes for several major chronic conditions and has received the support of investors including Nobel laureate Dr. Wally Gilbert and XPRIZE founder Dr. Peter Diamandis. Blake also serves on the board of the Institute for Family Medicine in St. Louis, MO.
Prior to founding Epharmix, Blake co-founded the education technology company Beatbox Labs, scaling to dozens of universities across the U.S. Blake’s passion for both technology and research originated during his work in nuclear medicine, which was awarded top prize at Intel’s 2011 International Science and Engineering Fair.
- Preparing for the Birth of New Patient Data - Monday, May 7, 3:40pm-4:20pm